Here's an articulation of why car people love wagons so much—and why we're bummed that this car's production is ending in ...

Fintel reports that on March 5, 2026, Benchmark upgraded their outlook for Cross Country Healthcare (NasdaqGS:CCRN) from Hold to Buy. Analyst Price Forecast Suggests 27.10% Upside As of February 25, ...

Cross Country Healthcare (CCRN) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.04 per share a year ago. These figures ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Cross Country Healthcare (CCRN) reports results for the quarter ended December 2025. While this widely-known consensus ...

Fintel reports that on March 5, 2026, Benchmark upgraded their outlook for Cross Country Healthcare (NasdaqGS:CCRN) from Hold to Buy. As of February 25, 2026, the average one-year price target for ...

Cross Country Healthcare saw its merger with Aya Healthcare collapse after the government shutdown pushed back the HSR waiting period expiration date. CCRN will receive a $20 million termination fee ...

Fintel reports that on December 9, 2025, UBS maintained coverage of Cross Country Healthcare (NasdaqGS:CCRN) with a Neutral recommendation. As of December 6, 2025, the average one-year price target ...

As we get into another winter holiday season, COVID is still part of our lives. And although it's hard to predict exactly what this year's cold, flu and coronavirus season will look like, experts want ...

"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...